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Purpose: Keratoconus (KC) is a bilateral and noninflammatory disease, characterized by
progressive thinning and anterior protrusion of the cornea and may result in severe visual
impairment due to irregular astigmatism. Matrix metalloproteinases (MMP) are the main group of
enzymes that degrade extracellular matrix proteins including collagens; Type IV collagen is found
in the corneal stroma.MMPenzymatic activity is inhibited by tissue inhibitor ofmetalloproteinase-1
(TIMP-1). A decrease in TIMP-1 level is associatedwith the development of KC. In the present study,
we investigated the impact of COL4A4 rs2228557 C/T and TIMP-1 rs4898 C/T (X-chromosome)
variants on the odds of KC development in a sample of Iranian population.
Methods: This case–control studywas conducted on 140 patients with KC and 150 healthy control
subjects. We used modified methods of Nested-PCR and ARMS-PCR in combination (Nested-
ARMS-PCR) and confirmed their validity with RFLP–PCR.
Results: Significant differences were noticed between KC patients and healthy individuals
regarding the genotype TY or T allele frequencies of rs4898 in the male subjects (OR = 0.43,
95%CI: 0.20–0.92, P = 0.03), whereas no significant differences were identified in the female
subjects (OR = 1.07, 95%CI: 0.52–2.20, P = 0.85). The rs2228557, T allele was associated with
KC (OR = 0.69, 95% CI: 0.50–0.97, P = 0.035).
Conclusion: In the rs2228557 variant, T allele acts as a protective factor from the disease and
decreases the risk of KC compared with the C allele. Also, in our investigation about rs4898, we
found that TY genotype or T allele decreased the risk of KC compared with the C allele in males
and was a protective factor for KC in our population.
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Keratoconus (KC) is defined as a bilateral,
non-inflammatory, and progressive disease
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characterized by conical protrusion of the cornea.
This diseasemay result in severe visual impairment
due to irregular astigmatism and stromal scarring.
KC eventually affects both eyes, although the
involvement is usually asymmetric. The symptoms
of KC-affected patients are different depending
on the stage of the disease.[1–3] Glasses or
contact lenses can provide useful vision in
the early stage of the disease; nonetheless,
corneal transplantation is mandatory for visual
rehabilitation in 20% of the patients who are in
advanced stage. Corneal thinning is considered as
one of the identifying characteristics of KC. Central
corneal thickness (CCT) is lower in KC patients by
75 µm as compared to normal controls.[4, 5]
The incidence of KC is approximately 1 per
2,000, and its prevalence is 54.5 per 100,000. This
disease occurs in both genders,[6] with different
rates among different ethnic groups.[7] KC usually
begins in teens, and its progression slows after the
age of 30 years.[6]
KC is a multi-factorial disorder; environmental
factors cause KC in genetically susceptible
individuals. The environmental factors that may
play roles in the pathogenesis of KC include eye
rubbing, allergy, connective tissue dysfunction,
and contact lens wear. Moreover, subjects with a
family history of KC are more susceptible to this
disorder.[8] Using family-based linkage, several
case–control studies have determined various
genes that increase the odds of KC development.[9]
The gene candidates for KC include LOX,[10]
VSX1,[11] GPX-1,[12] TGF-𝛽1,[13] COL4A3 and
COL4A4[14] (polymorphism or mutation), and TIMP-
1,[15] MMP-2, MMP-9[16] (gene expression). KC is still
an enigmatic disease in many aspects, including
inheritance, basic pathophysiology, prevention,
associated risk factors, disease development, as
well as therapeutic approaches.[17]
Type IV collagen is only present in basement
membranes and constitutes their main structural
component. Collagen type IV gene, alpha-4
(COL4A4), is located in the region 2q35–q37
with a gene span composed of 113 kb and 48
exons.[18, 19] Type IV collagen is not expressed in
cornea in the normal condition and its presence
indicates a corneal pathology; therefore, type
IV collagen can be a potential candidate in the
pathogenesis of KC. In support of this theory,
alterations in the expression level of collagen
type IV (α-4 chains) were observed in corneas
inflicted by KC.[20, 21] Matrix metalloproteinases
(MMP) are the major expressed metalloproteases
in the cornea. It has been demonstrated that the
proteolytic activity of MMP increases in KC. This
finding suggests that abnormal MMP activity plays
a role in the pathogenesis of KC.[16, 22]
Four types of tissue inhibitor of
metalloproteinase (TIMP1-4) have been detected;
three of which, including TIMPs-1, 3, and 4, are
nested within an intron in the genes of synapsins.
TIMP inhibits collagenases and proteoglycanase
called matrix metalloproteinase. All four types
of TIMPs have various biological activities apart
from their metalloproteinase inhibitory activity.
These biological activities include the promotion
of cell proliferation, cancer promotion, regulation
of angiogenesis, as well as pro- and anti-apoptotic
and synaptic flexibility activities, many of which are
independent of metalloprotease inhibition. TIMP-1
is associated with synapsin 1 and its gene is located
in X11p11.23–11.4 consisting of six exons. Mature
TIMP-1 is a 28.5 kDa glycoprotein that consists of
184 amino acid residues. The natural precursor
contains a signal peptide of 23 residues which are
cleaved throughout the protein maturation.[23–27]
TIMP-1 suppresses angiogenesis and controls
the balance in the corneal tissue by inhibiting
the action of matrix metalloproteinase to protect
tissues from permanent damage.[28] Furthermore,
it has been demonstrated that increased MMP and
decreased TIMP levels are associated with the
development of KC.[29]
COL4A4 gene rs2228557 (F1644F)
(HGVM1660028) is located in chromosome
2 exon 48, NM_000092.4 region. Several
studies examined the association between
COL4A4 and KC and revealed that this gene
is associated with KC; however, some other
studies failed to find the same relationship in
different populations.[14, 22, 30, 31]
TIMP-1 gene rs4898 (+372C/T) (HGVM6380940)
is located within the intron of the synapsin gene,
and single nucleotide polymorphism (SNP) is
located in exon 5, the region of NM_006950.3.
Some studies investigated the association of
rs4898 gene polymorphism with disorders
including intracerebral hemorrhage,[32] systemic
sclerosis,[33] and severe sepsis.[34]
The present study aimed to evaluate the
possible association of TIMP-1 rs4898 C/T gene
polymorphism and COL4A4 rs2228557 C/T gene
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polymorphism with the development of KC in a
sample of Iranian population.
METHODS
Patients
The current retrospective case–control study was
conducted at the Alzahra Eye Hospital, Zahedan
University of Medical Sciences, Zahedan, Iran
and recruited 140 unrelated Iranian patients
with KC and 150 unrelated healthy controls.
The patients were diagnosed with KC after a
comprehensive ophthalmic examination using the
following criteria: (1) clinical signs of KC (Munson
sign, protrusion, Vogts striae, corneal thickness,
scarring, Fleischer ring) and abnormal findings
in corneal topography (Pentacam AXL, OCULUS
INC); (2) the three quantitative videokeratographic
indices used for the screening of KC were central
corneal power > 47.2 D, inferior–superior value >
1.4 D, Sim-K astigmatism > 1.5 D, and skewed radial
axes> 21°.[10, 35] Patients with other ocular diseases
were excluded from the study. Controls were sex-
and age-matched healthy participants who were
unrelated to the patients and were selected from a
geographic area similar to that of KC subjects.
The Ethics Committee of Zahedan University
of Medical Sciences, Zahedan, Iran approved the
study protocol and informed consent was signed by
all participants. This study complied with the tenets
of the Declaration of Helsinki.
Analysis of the TIMP-1 (rs4898), COL4A4
(rs2228557) Polymorphisms
Blood samples were collected in EDTA-containing
tubes and genomic DNA was extracted from the
peripheral blood leukocytes using salting out
method as previously described.[36] All procedures
were performed under a standardized setting to
avoid variation in DNA quality. SNP rs2228557
COL4A4 was evaluated by ARMS–PCR. For
the detection of rs4898 TIMP-1, we used the
combination of Nested-polymerase chain reaction
(Nested-PCR)[37] and amplification refractory
mutation system-PCR(ARMS-PCR)[38] (Nested-
ARMS-PCR). The verification of these methods was
accomplished using Restriction Fragment Length
Polymorphism (RFLP-PCR).[39]
The rs4898 location was very challengeable for
ARMS-PCR; therefore, for the detection of the SNP,
we used Nested or hemi-Nested-PCR primers, as
mentioned previously.[40] The advantages of this
modification include elimination of non-specific
products, protection of SNP position for the next
steps, low cost, and short duration of the process.
PCR reactions were performed using PCR
master mix (Ampliqon Taq 2x mastermix, Denmark)
according to the manufacturer’s instructions. For
investigation of COL4A4 (rs2228557), amplification
reaction was provided in 20 μL volume including: 1
μL template DNA (∼100 ng/μL), 1 μL of each primer
(10 pmol/μL), 10 μL mastermix, and 7 μL DNase-free
water. The PCR conditions were set as follow: 95°C
for 5 min, 30 cycles of 95°C for 30 sec, 55°C for
35 sec, 72°C for 30 sec, and a final extension at
72°C for 5 min. PCR products were detected by
electrophoresis on a 2% agarose gel staining by
ethidium bromide (Figure 1A).
In the first stage of study for TIMP-1 rs4898,
Nested-PCR reaction was performed in 20 μL
volume including: 1 μL template DNA (∼100 ng/μL),
1 μL of each primer (10 pmol/μL), 10 μL mastermix,
and 7 μL DNase-free water. The PCR conditions
were set as follow: 95°C for 5 min, 30 cycles of
95°C for 30 sec, 64°C for 40 sec, 72°C for 30 sec,
and a final extension at 72°C for 5 min. In the
second phase, the PCR product obtained from the
first stage (660 bp) was used as the template and
diluted 1:50. Primers for ARMS-PCR were designed
to detect the SNP (Table 1). In this step, ARMS-PCR
reaction was performed in 20 μL volume including:
1 μL template (1:50 dilution), 1 μL of each primer (10
pmol/μL), 10 μL mastermix, and 7 μL DNase-free
water. The PCR conditions were set as follow: 95°C
for 5 min, 17 cycles of 95°C for 30 sec, 56°C for
30 sec, 72°C for 30 sec, and a final extension at
72°C for 5 min. PCR products were detected by
electrophoresis on a 2% agarose gel staining by
ethidium bromide (202bp product). Consequently,
SNP (rs4898) TIMP-1 was successfully detected
with the combination of two methods (Nested-PCR
and ARMS-PCR) (Figures B1 & B2).
RFLP-PCR was applied to validate the method
and results of screening of rs4898 polymorphism
in TIMP-1. As the original sequence of the
region surrounding the polymorphism does
not make a restriction enzyme site, a site-directed
mutagenesis PCR primer (R*) was designed. This
primer differs from the referent sequence in two
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Figure 1. Electrophoresis pattern for the detection of SNPs in COL4A4 rs2228557 and TIMP-1 rs4898.
(A) Arms-PCR products of COL4A4 rs2228557, M: DNAmarker (100 bp). (B1) TIMP-1 rs4898, Nested-PCR products, M: DNAmarker
(100bp), product size (660 and 344bp), respectively. (B2) ARMS-PCR products, product size (202bp), (TT, TC, CC) demonstrate
genotypes. (B3) RFLP-PCR products, M: DNA marker (50bp), product sizes were 344bp for TT, 344bp and 325bp for TC, 325bp
for CC in female, 344bp for TY and 325bp for CY in male, (TT, TC, CC) demonstrate female and (TT = TY, CC = CY) demonstrate
male genotypes, (Y stands for the Y-chromosome).
Table 1. The list of primers and methods used for detection of Single Nucleotide Polymorphisms (SNPs) TIMP-1 rs4898 and
COL4A4 rs2228557
TIMP-1(rs4898) T/C Primers(5’-3’) Product size




202 bpR (C allele) CAGATTGTTCCAGGGAGCCAAG
R (T allele) CAGATTGTTCCAGGGAGCCAAA





183 bpR (C allele) GAGCCAGAAGCTATACTTATTTGAG
R (T allele) GAGCCAGAAGCTATACTTATTTGAA
F, forward; R, reverse; R*, altered reverse
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Table 2. Genotype and allelic frequencies of COL4A4 rs2228557 and TIMP-1 rs4898 polymorphisms between keratoconus
(KC) patients and healthy controls.
Variants KC Patients n (%) Controls n (%) *OR (95% CI) P-value
rs2228557,COL4A4
CC 67 (47.8) 61 (40.7) Ref. —
CT 39 (27.9) 37 (24.7) 0.96 (0.54–1.69) 0.887
TT 34 (24.3) 52 (34.6) 0.59 (0.34–1.03) 0.067
Allele
C 173 (61.8) 159 (53) Ref. —
T 107 (38.2) 141 (47) 0.69 (0.50–0.97) 0.035
rs4898,TIMP-1 Male Male
CY 46 (75.4) 37 (57) Ref. —
TY 15 (24.6) 28 (43) 0.43 (0.20–0.92) 0.038
Female Female
CC 28 (47.5) 31 (52.5) Ref. —
CT 29 (49.2) 30 (50.8) 1.01 (0.46–2.19) 0.97
TT 22 (47.8) 24 (52.2) 1.07 (0.52–2.20) 0.854
Allele
C 85 (53.8) 92 (54.1) Ref. —
T 73 (46.2) 78 (45.9) 1.01 (0.66–1.56) 0.953
Ref., reference; OR, odds ratio; CI, confidence interval; n, number *Adjusted for sex and age. (Y states for the Y-chromosome)








0.25 0.39 0.4OS 36 (25.7)
OU 62 (44.3)
Level of KC
KK 1 33 (23.6)
0.81 0.014 0.97KK 2 45 (32.1)
KK 3 62 (44.3)
CXL
OD 39 (27.9)
0.58 0.71 0.37OS 40 (28.6)
OU 42 (30.0)
Candidate 19 (13.6)
Correlation of clinical and keratometric parameters with COL4A4 (rs2228557) and TIMP-1 (rs4898) in keratoconus patients.
KC, keratoconus; OD, right eye; OS, left eye; OU, both eyes; CXL, cross-linking surgery
KK1, 2, 3 are phenotyping classification and show the level progress of keratoconus disease in patients
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bases and lies close to the polymorphic spot to
alter the sequence and provide a restriction
enzyme site at product. Thus, the original
sequence of the region is TT(C) GTGG, while
our PCR product was in fact TT(C) GCGA. The
C-variant is a palindrome which forms a site for
the Bsp68I (NruI) restriction enzyme (Thermo
scientific).[40]
Initially, we amplified PCR product (660bp) using
the abovementioned conditions. For alteration in
the restriction enzyme site, secondary primers
were added to template 1:50 dilution of first stage
using the following condition: 1 μL template (1:50
dilution), 1 μL of each primer (10 pmol/μL), 10
μL mastermix, and 7 μL DNase-free water. The
PCR conditions were set as follow: 95°C for 5
min, 30 cycles of 95°C for 30 sec, 63°C for 30
sec, 72°C for 30 sec, and a final extension at
72°C for 5 min. PCR products were detected by
electrophoresis on a 2% agarose gel with ethidium
bromide (344bp product). For optimal results, PCR
products were digested at 37°C for 5 h according to
themanufacturer’s instruction. The restriction of the
C-allele PCR product resulted in 325bp and 19bp
digest products, whereas the T allele (wild type)
products remained unrestricted (Figure B3).
Statistical analysis
Statistical analyses were performed using the SPSS
software version 19.0 (SPSS Inc., Chicago IL, USA).
Frequencies were compared between the study
groups using the Chi-square test. Association of
gene polymorphisms with KC was investigated
and compared between the groups using logistic
regression analysis, estimation of odds ratio (OR),
and 95% confidence intervals (CI), respectively.
A p-value < 0.05 was regarded as statistically
significant.
RESULTS
A total of 140 patients (61 male and 79 female
subjects), aged 28 ± 12.5 years, included the KC
group. The control group consisted of 150 healthy
controls (65 male and 85 female subjects), aged
29.8 ± 15.6 years.
There was no significant difference between the
two groups regarding the age and gender (P =
0.20).
The Col4A4 rs2228557 C/T variant, T allele
was associated with a decrease in the risk of KC
development (OR = 0.69, 95% CI: 0.50–0.97, P
= 0.035), as compared to C allele. Our results
indicated that TT was not associated with KC as
compared to CC (OR = 0.59, 95% CI = 0.34–1.03,
P = 0.067) (Table 2).
Table 2 demonstrates the genotype and
allelic frequencies of TIMP-1 (rs4898) gene
polymorphism in each study group. Since TIMP-1
is an X-linked gene, the results were compared
in male and female subjects separately. This
analysis demonstrated that TY genotype or T
allele decreased the risk of KC in male subjects
as compared to the C allele (OR = 0.43, 95% CI:
0.20–0.92, P = 0.03). However, no significant
association was found between TT genotype (OR
= 1.07, 95% CI: 0.52–2.20, P = 0.854) or T allele
(OR = 1.01, 95%CI: 0.66–1.56, P = 0.95) and KC in
female subjects.
Table 3 illustrates the associations of COL4A4
(rs2228557) and TIMP-1 (rs4898) with KC severity.
This polymorphism TIMP1 (rs4898 T/C) located
at X chromosome exists in two alleles and their
combination results in five possible genotypes.
Because men lack a second X-chromosome, the
possible genotypes are CY and TY hemizygotes (Y
states for the Y-chromosome). As for women, there
are CC and TT homozygotes and CT heterozygotes
(Table 2). In fact, men just have allele and
women have genotype and allele. For this reasons,
calculation of TIMP1 (rs4898) distinctly separated in
men and women was done. So, results in men and
women can be different.
DISCUSSION
Keratoconus is an eye disorder characterized
by bilateral, asymmetrical, noninflammatory, and
progressive thinning of the cornea. The shape of
cornea progressively alters from the normal round
shape to a cone shaped one. Although the etiology
of KC is not clear, defective cross-linking between
adjacent collagen fibers may play an important
role in its pathogenesis.[41] SNPs and gene variants
suggest an intricate etiology or the convergence of
multiple disease pathways.[42]
Biochemical investigations have suggested that
the amount of collagen fibers decrease in KC. Also,
the weight of KC corneas was found to be reduced;
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therefore, it can be assumed that collagenase
enzymes might be involved.[43]
In the current study, we investigated the impact
of COL4A4 and TIMP-1 variants on the risk of KC
development in a sample of Iranian population. Our
results showed that the T allele reduced the risk of
disease development, as compared to the C allele.
Results in the distribution of genotypes (CC, CT,
TT) in rs2228557 of the COL4A4 gene between
KC patients and controls in the Stabuc-Silih et al’s
study were different from our results.[14] Similar to
our findings, Kokolakis et al demonstrated that the
TT genotype was significantly over-represented in
healthy individuals and suggested a protective role
for this genotype in the KC development.[31]
The level of TIMP-1 significantly decreases in
KC as compared to normal corneas. Given the
fact that KC is not associated with extensive
scarring or inflammatory infiltrates, substantial
degradation should occur in the extracellular
matrix. A decreased level of TIMP-1 increases
gelatinase and collagenase activities and
apoptosis which are characteristic phenomena in
KC. Decreases in TIMP-1 might play a role in matrix
degradation which is a characteristic feature of
KC.[15, 44] Furthermore, it has been recognized that
increased MMP and decreased TIMP-1 levels are
associated with the development of KC.[29]
The TIMP-1 gene is located in Xp11.3–p11.23 and
has three types of polymorphism including TIMP-
1 (19 C/T) in the 5’-UTR, TIMP-1 (261 C/T) in exon
4, and TIMP-1 (372 T/C) (rs4898) in exon 5. The
TIMP-1 (rs4898) polymorphism is an important site
which has been reported in other studies. This
variation does not result in changes in the amino
acid sequence (F124F). This polymorphism exists
in two alleles and their combination results in five
possible genotypes. Because male subjects lack
a second X-chromosome, the possible genotypes
are CY and TY hemizygotes. In female subjects,
however, there are CC and TT homozygotes and
CT heterozygote genotypes.[40]
Our data suggest that C or T allele is associated
with TIMP-1 (rs4898) polymorphism in patients or
controls. The C allele of the 372T/C polymorphism
was more frequently found in female than male
controls.[45] However, in other studies, the C
allele was detected more frequently in male
patients with an abdominal aortic aneurysm.[46]
Meijer et al investigated the male subjects with
inflammatory bowel disease carrying TIMP-1
(rs4898) T allele. They reported lower levels of
TIMP-1 in surgically resected inflamed tissue,
as compared to C allele carriers.[47] In addition,
Indelicato et al reported that TIMP-1 (rs4898)
C allele frequency increased in males but not
females with systemic sclerosis, as compared to
healthy individuals.[48] Along the same lines, Wei et
al revealed that C allele carriers of TIMP-1 (rs4898)
run a greater risk of developing ankylosing
spondylitis disease.[49] Furthermore, it was found
that among cirrhotic patients, males with TIMP-1
(372C/T) T allele developed cirrhosis at a younger
age.[50]
Our findings indicated that TIMP-1 (rs4898) was
associated with the clinical characteristics of KC
only in our male sample population. Nevertheless,
the analysis of genotype and allele frequencies
revealed no significant differences in female
patients as compared to female controls. The T
allele decreased the risk of KC, as compared to
the C allele in males which can be attributed to the
location of TIMP-1 gene at Xp11.3–p11.23. Males
only have one X-chromosome, and the functional
difference of genetic polymorphism of TIMP-
1 (rs4898) appears more obvious due to the
lack of heterozygotes. We cannot compare
our results with the literature because no
previous study has evaluated the correlation
between the TIMP-1 variants and the risk of KC
development.
In conclusion, our study showed that in the
COL4A4 rs2228557 C/T variant, the T allele acts
as a protective factor against the disease and
decreases the risk of KC. In addition, TIMP-1 rs4898
C/T the TY genotype or T allele in males can
decrease the risk of KC in comparison with the C
allele. Further studies with a larger sample size and
different ethnicities are required to confirm these
findings.
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